Life After Lockdown

Why Covid-19 Vaccines Might Be Big Pharma’s Last Big Chance to Repair Its Reputation

Most Americans don't like or trust pharmaceutical firms, but maybe a needle stick can change their minds

Not since the polio vaccine breakthrough of the 1950s has the pharmaceutical industry had the chance to look as noble as it does now. Photo Illustration: Trent Joaquin

By Robert Klara

February 26, 2021

On Dec. 8, 2020, a 90-year-old woman sat in a high-backed chair at the University Hospital in Coventry, U.K., and entered the history books.

The Business of Marketing

Don't miss The Business of Marketing, a new series featuring leading c-suite executives sharing insights on the importance of leveraging the intersectionality of marketing, finance, technology, HR and the boardroom to drive business growth. Tune in.

Robert Klara
@UpperEastRob robert.klara@adweek.com Robert Klara is a senior editor, brands at Adweek, where he specializes in covering the evolution and impact of brands.
Recommended articles
You Might Like

While Talk of the Post-Pandemic Future Is on the Rise, SMBs Continue to Struggle

By Lorenzo Papa, Chief Revenue Officer, Captivate

Why Print Matters More Than Ever in a Post-Pandemic World

By Tonya Powers, Director of Marketing Production Print Solutions, Canon Solutions America

3 New Behaviors of Media Consumers and What to Do About Them

By Zephr

Why Healthcare Marketers Are Turning to Streaming Audio to Build Vaccine Confidence

By Anna Clement

{"channel":"elasticpress","title":"Recommended","post_types":["post","page"],"lineup_id":"54851","since_qty":30,"since_time":"d","until_qty":0,"until_time":"m","q":"","num_posts":0,"vertical":"brand-marketing"}